Atlas Trials

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Clinical trial NCT03295695 · WITHDRAWN

Trial details

NCT number
NCT03295695
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
WITHDRAWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Breast CancerBreast Cancer, FemaleBreast Cancer, MaleBreast Neoplasms
Start date
2020-12-01
Primary completion
2021-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.